Dartmouth stem cell study 1st successful clinical trial for autoimmune disease
from The Dartmouth
Patients with hard-to-treat scleroderma will be happy to learn that an effective therapy for their painful autoimmune rheumatic disease may be soon in sight. A multi-center study by researchers at Dartmouth and other institutions found that a subset of patients who suffer from scleroderma are more likely to benefit from hematopoietic stem cell transplant than cyclophosphamide, the more standard drug therapy.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063